- GlobeNewswire•26 days ago
NORTHVALE, N.J., Aug. 29, 2016-- Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced it has entered into a Development ...
- GlobeNewswire•last month
NORTHVALE, N.J., Aug. 10, 2016-- Elite Pharmaceuticals, Inc. today announced that it has filed an Abbreviated New Drug Application with the US Food and Drug Administration for a generic version of Percocet ...
Elite Pharmaceuticals, Inc. (ELTP)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.17 - 0.17|
|52wk Range||0.11 - 0.44|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.31|
|Avg Vol (3m)||2,141,784|
|Dividend & Yield||N/A (N/A)|